Literature DB >> 24424782

Effects of Δ9-tetrahydrocannabinol in individuals with a familial vulnerability to alcoholism.

Mohini Ranganathan1, R Andrew Sewell, Michelle Carbuto, Jacqueline Elander, Ashley Schnakenberg, Rajiv Radhakrishnan, Brian Pittman, Deepak Cyril D'Souza.   

Abstract

BACKGROUND AND AIMS: A family history (FH) of alcoholism accounts for approximately 50% of the risk of developing alcohol problems. Several lines of preclinical evidence suggest that brain cannabinoid receptor (CB1R) function may mediate the effects of alcohol and risk for developing alcoholism including the observations that reduced CB1R function decreases alcohol-related behaviors and enhanced CB1R function increases them. In this first human study, we probed CB1R function in individuals vulnerable to alcoholism with the exogenous cannabinoid Δ(9)-tetrahydrocannabinol (Δ(9)-THC). DESIGN, SETTING, AND PARTICIPANTS: Healthy volunteers (n = 30) participated in a three test day study during which they received 0.018 and 0.036 mg/kg of Δ(9)-THC, or placebo intravenously in a randomized, counterbalanced order under double-blind conditions. MEASUREMENTS: Primary outcome measures were subjective "high," perceptual alterations, and memory impairment. Secondary outcome measures consisted of stimulatory and depressant subjective effects, attention, spatial memory, executive function, Δ(9)-THC and 11-hydroxy-THC blood levels, and other subjective effects. FH was calculated using the Family Pattern Density method and was used as a continuous variable.
FINDINGS: Greater FH was correlated with greater "high" and perceptual alterations induced by Δ(9)-THC. This enhanced sensitivity with increasing FH was specific to Δ(9)-THC's rewarding effects and persisted even when FH was calculated using an alternate method.
CONCLUSIONS: Enhanced sensitivity to the rewarding effects of Δ(9)-THC in high-FH volunteers suggests that alterations in CB1R function might contribute to alcohol misuse vulnerability.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24424782     DOI: 10.1007/s00213-013-3402-4

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  43 in total

Review 1.  Move over ANOVA: progress in analyzing repeated-measures data and its reflection in papers published in the Archives of General Psychiatry.

Authors:  Ralitza Gueorguieva; John H Krystal
Journal:  Arch Gen Psychiatry       Date:  2004-03

2.  Ultrasensitive measurement of delta-9-tetrahydrocannabinol with a high energy dynode detector and electron-capture negative chemical-ionization mass spectrometry.

Authors:  L M Shaw; J Edling-Owens; R Mattes
Journal:  Clin Chem       Date:  1991-12       Impact factor: 8.327

3.  Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism.

Authors:  G Tanda; F E Pontieri; G Di Chiara
Journal:  Science       Date:  1997-06-27       Impact factor: 47.728

4.  Ethanol self-administration and ethanol conditioned place preference are reduced in mice lacking cannabinoid CB1 receptors.

Authors:  Panayotis K Thanos; Elias S Dimitrakakis; Onarae Rice; Andrew Gifford; Nora D Volkow
Journal:  Behav Brain Res       Date:  2005-11-07       Impact factor: 3.332

5.  Family history models of alcoholism: age of onset, consequences and dependence.

Authors:  W M Turner; H S Cutter; T G Worobec; T J O'Farrell; R D Bayog; M T Tsuang
Journal:  J Stud Alcohol       Date:  1993-03

6.  The balanced placebo design: methodological considerations.

Authors:  D J Rohsenow; G A Marlatt
Journal:  Addict Behav       Date:  1981       Impact factor: 3.913

7.  The safety of studies with intravenous Δ⁹-tetrahydrocannabinol in humans, with case histories.

Authors:  Michelle Carbuto; R Andrew Sewell; Ashley Williams; Kim Forselius-Bielen; Gabriel Braley; Jacqueline Elander; Brian Pittman; Ashley Schnakenberg; Savita Bhakta; Edward Perry; Mohini Ranganathan; Deepak Cyril D'Souza
Journal:  Psychopharmacology (Berl)       Date:  2011-08-16       Impact factor: 4.530

8.  Targeting dopamine D2 and cannabinoid-1 (CB1) receptors in rat nucleus accumbens.

Authors:  Virgina M Pickel; Jane Chan; Christopher S Kearn; Kenneth Mackie
Journal:  J Comp Neurol       Date:  2006-03-20       Impact factor: 3.215

9.  Delta9-THC reinstates beer- and sucrose-seeking behaviour in abstinent rats: comparison with midazolam, food deprivation and predator odour.

Authors:  Iain S McGregor; Kristy D B Dam; Paul E Mallet; Jason E Gallate
Journal:  Alcohol Alcohol       Date:  2004-11-18       Impact factor: 2.826

10.  Evaluating measures of family history of alcoholism: density versus dichotomy.

Authors:  S F Stoltenberg; S A Mudd; F C Blow; E M Hill
Journal:  Addiction       Date:  1998-10       Impact factor: 6.526

View more
  3 in total

1.  Selective breeding for high alcohol preference is associated with increased sensitivity to cannabinoid reward within the nucleus accumbens shell.

Authors:  Sheketha R Hauser; Simon N Katner; Robert A Waeiss; William A Truitt; Richard L Bell; William J McBride; Zachary A Rodd
Journal:  Pharmacol Biochem Behav       Date:  2020-07-23       Impact factor: 3.533

2.  Neurophysiological Correlates and Differential Drug Response in Subjects With a Family History of an Alcohol Use Disorder.

Authors:  Sage M Comstock; Jatin G Vaidya; Mark J Niciu
Journal:  Chronic Stress (Thousand Oaks)       Date:  2019-08-30

3.  Nursing Students' Knowledge and Attitudes Regarding Medical Marijuana: A Descriptive Cross-Sectional Study.

Authors:  Laura Pereira; María Jesús Núñez-Iglesias; Eva María Domínguez-Martís; David López-Ares; Mercedes González-Peteiro; Silvia Novío
Journal:  Int J Environ Res Public Health       Date:  2020-04-06       Impact factor: 3.390

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.